Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B, Drakopanagiotakis F, Bandelli GP, von der Beck D, Tello S, Cordani E, Rizza E, Barrocu L, Markart P, Seeger W, Guenther A, Albera C. Loeh B, et al. Among authors: tello s. Am J Respir Crit Care Med. 2015 Jan 1;191(1):110-3. doi: 10.1164/rccm.201406-1106LE. Am J Respir Crit Care Med. 2015. PMID: 25551350 No abstract available.
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, Müller V, Bonniaud P, Vancheri C, Wells A, Vasakova M, Pesci A, Sofia M, Klepetko W, Seeger W, Drakopanagiotakis F, Crestani B. Guenther A, et al. Among authors: tello s. Respir Res. 2018 Jul 28;19(1):141. doi: 10.1186/s12931-018-0845-5. Respir Res. 2018. PMID: 30055613 Free PMC article.
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: tello s. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg).
Krauss E, van der Beck D, Schmalz I, Wilhelm J, Tello S, Dartsch RC, Mahavadi P, Korfei M, Teschner E, Seeger W, Guenther A. Krauss E, et al. Among authors: tello s. J Clin Med. 2021 Jan 7;10(2):192. doi: 10.3390/jcm10020192. J Clin Med. 2021. PMID: 33430489 Free PMC article.
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg).
Krauss E, El-Guelai M, Pons-Kuehnemann J, Dartsch RC, Tello S, Korfei M, Mahavadi P, Breithecker A, Fink L, Stoehr M, Majeed RW, Seeger W, Crestani B, Guenther A. Krauss E, et al. Among authors: tello s. J Clin Med. 2020 Aug 3;9(8):2499. doi: 10.3390/jcm9082499. J Clin Med. 2020. PMID: 32756496 Free PMC article.
About spirals and pores: Xylariaceae with remarkable germ loci.
Voglmayr H, Tello S, Jaklitsch WM, Friebes G, Baral HO, Fournier J. Voglmayr H, et al. Among authors: tello s. Persoonia. 2022 Dec 20;49:58-98. doi: 10.3767/persoonia.2022.49.02. Epub 2022 Aug 13. Persoonia. 2022. PMID: 38234381 Free PMC article.
70 results